Table 8.
Effects of lymphocyte subsets on COPD re‑admission with a 2-year follow-up
| Variables | Re‑admission (N = 49) | No Re‑admission (N = 75) | P Value | ||
|---|---|---|---|---|---|
| N | Value | N | Value | ||
| T lymphocytes%b | 49 | 70.1(62.3,75.9) | 75 | 64.7(57.8,74.1) | 0.13 |
| CD4+ T cells%a | 49 | 40.03 ± 10.59 | 75 | 38.71 ± 10.84 | 0.50 |
| CD8+ T cells%b | 49 | 25.9(19.2,32.1) | 75 | 24.6(18.1,32.1) | 0.70 |
| CD4+CD8+ T cells%b | 49 | 0.71(0.38,1.07) | 75 | 0.91(0.53,1.48) | 0.04 |
| CD4−CD8− T cells%b | 49 | 1.48(0.66,3.37) | 75 | 1.75(0.71,3.30) | 0.55 |
| NK cells%b | 49 | 18.4(10.1,26.3) | 75 | 19.2(11.6,29.9) | 0.43 |
| T4/T8 ratio%b | 49 | 1.59(1.07,2.12) | 75 | 1.66(1.17,2.40) | 0.94 |
| B lymphocytes%b | 49 | 11.4(7.3,17) | 75 | 11.7(7.5,16.3) | 0.83 |
COPD chronic obstructive pulmonary disease, NK cells, natural killer cells
Data are expressed as
amean ± SD
bmedian; 25–75th percentile
P values: to evaluate the differences between the two groups, an independent t-test was used to analyze the normally distributed continuous variables; the Mann–Whitney U test was used to analyze the non-normally distributed variables